Please login to the form below

Not currently logged in
Email:
Password:

drug abuse

This page shows the latest drug abuse news and features for those working in and with pharma, biotech and healthcare.

AcelRX’s potent opioid tablets set to win FDA backing for pain relief

AcelRX’s potent opioid tablets set to win FDA backing for pain relief

This time the application included a Risk Evaluation Mitigation Strategy (REMS), stating that the drug must be administered by a trained healthcare professional to avoid substance abuse and accidental exposures. ... This measure has helped to swing the

Latest news

  • FDA panel backs Indivior’s drug to fight opioid addiction FDA panel backs Indivior’s drug to fight opioid addiction

    FDA panel backs Indivior’ s drug to fight opioid addiction. The former RB pharma unit hopes for sales in the $1bn region. ... Indivior is on course to bring a new drug to market to tackle painkiller addiction in the US, offsetting the risks to its

  • FDA panel backs Pfizer and Teva abuse-resistant painkillers FDA panel backs Pfizer and Teva abuse-resistant painkillers

    However, it would not back a label claim that the product could prevent abuse of the drug via the oral route, but said it could discourage abuse by people seeking to ... Last month the same panel also rejected an abuse-deterrent claim for KemPharm's

  • FDA gives green light for opioid addiction implant FDA gives green light for opioid addiction implant

    He added: “ Opioid abuse and addiction have taken a devastating toll on American families. ... Nora Volkow, director of the National Institute on Drug Abuse, said: “ Scientific evidence suggests that maintenance treatment with these medications in

  • FDA panel backs Novo Nordisk's liraglutide for obesity FDA panel backs Novo Nordisk's liraglutide for obesity

    FDA panel backs Novo Nordisk's liraglutide for obesity. Committee says diabetes drug could be used to reduce weight. ... Orexigen said yesterday that Contrave will have the benefit of a large Takeda salesforce promoting the drug and no need for

  • Acura must provide FDA more info on pain drug Acura must provide FDA more info on pain drug

    Acura must provide FDA more info on pain drug. Regulator questions abuse-resistant ability of Aversion. ... The FDA has demanded that Acura Pharmaceuticals submit more evidence on the abuse-deterrent abilities of its investigational pain drug.

More from news
Approximately 3 fully matching, plus 28 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2013 Pharma deals during January 2013

    9.5. Savant HWP / National Institute on Drug Abuse. Development grant. ... 18-MC (18-methoxycoronaridine) as a treatment for drug addiction, obesity and compulsive behaviour.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • Breath Analyzers Market Value Chain and Forecast 2015-2025

    The growth of breath analyzer devices market is primarily attributed to increase in consumption of alcohol, drug abuse and growth in the incidences of diseases like tuberculosis, asthma and other diseases. ... Alcohol detection. Drug abuse detection.

  • "Legal highs" ruling leaves illegal labs laughing

    We have also pitched for agents designed to treat opioid overdose and alcohol abuse. ... Drug abuse is a massive medical and social problem in the UK, and it has been compounded by the availability of new psychoactive agents virtually everywhere.

  • "Legal highs" ruling leaves illegal labs laughing

    We have also pitched for agents designed to treat opioid overdose and alcohol abuse. ... Drug abuse is a massive medical and social problem in the UK, and it has been compounded by the availability of new psychoactive agents virtually everywhere.

  • How digital content is helping physicians curb the opioid abuse epidemic

    using their state’ s Prescription Drug Monitoring Program (PDMP) database before prescribing opioids to a patient. ... After all, having physicians more frequently access these state PMDPs at the point of prescription can go a long way to preventing

More from PMHub
Approximately 2 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics